JPS62201884A
(ja)
*
|
1986-02-28 |
1987-09-05 |
Tokyo Tanabe Co Ltd |
ベンズイミダゾール誘導体及びその製造法
|
JPH0768125B2
(ja)
*
|
1988-05-18 |
1995-07-26 |
エーザイ株式会社 |
酸不安定化合物の内服用製剤
|
AT391693B
(de)
*
|
1988-11-15 |
1990-11-12 |
Cl Pharma |
Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer
|
US5294629A
(en)
*
|
1988-11-22 |
1994-03-15 |
Meiji Seika Kaisha, Ltd. |
Benzothiazole and benzimidazole derivatives and antiulcer agent containing the same
|
SE8804629D0
(sv)
*
|
1988-12-22 |
1988-12-22 |
Ab Haessle |
New therapeutically active compounds
|
EG19302A
(en)
*
|
1988-12-22 |
1994-11-30 |
Haessle Ab |
Compound with gastric acid inhibitory effect and process for its preparation
|
US5049674A
(en)
*
|
1989-12-20 |
1991-09-17 |
Aktiebolaget Hassle |
Therapeutically active fluoro substituted benzimidazoles
|
US4965269A
(en)
*
|
1989-12-20 |
1990-10-23 |
Ab Hassle |
Therapeutically active chloro substituted benzimidazoles
|
ES2024357A6
(es)
*
|
1990-12-05 |
1992-02-16 |
Genesis Para La Investigacion |
Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina.
|
NZ244301A
(en)
*
|
1991-09-20 |
1994-08-26 |
Merck & Co Inc |
Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
|
US5504082A
(en)
*
|
1992-06-01 |
1996-04-02 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Pyridine compound and pharmaceutical compostions
|
DK0585722T3
(da)
*
|
1992-08-21 |
1996-08-05 |
Eisai Co Ltd |
Benzimidazolderivater som antimikrobielt middel mod Campylobacter pylon
|
ATE178603T1
(de)
*
|
1993-02-17 |
1999-04-15 |
Byk Gulden Lomberg Chem Fab |
Substituierte heteroarylalkylthiopyridine zur bekämpfung von helicobacter bakterien
|
EP0706523B1
(de)
*
|
1993-06-29 |
2001-01-24 |
Byk Gulden Lomberg Chemische Fabrik GmbH |
Substituierte arylthioalkylthiopyridine
|
TW280770B
(de)
|
1993-10-15 |
1996-07-11 |
Takeda Pharm Industry Co Ltd |
|
KR960705811A
(ko)
*
|
1993-10-29 |
1996-11-08 |
고오야 다다시 |
피리딘 화합물 및 그의 약학적 용도[pyridine compound and medicinal use thereof]
|
KR0142815B1
(ko)
*
|
1994-12-02 |
1998-07-15 |
정도언 |
신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체
|
KR0179401B1
(ko)
*
|
1994-02-28 |
1999-03-20 |
송택선 |
신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체
|
HRP960232A2
(en)
*
|
1995-07-03 |
1998-02-28 |
Astra Ab |
A process for the optical purification of compounds
|
US5824339A
(en)
*
|
1995-09-08 |
1998-10-20 |
Takeda Chemical Industries, Ltd |
Effervescent composition and its production
|
KR970032861A
(ko)
*
|
1995-12-29 |
1997-07-22 |
김준웅 |
헬리코박터 피로리 제거용 약제 투여방법
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
JP2002510293A
(ja)
*
|
1997-05-30 |
2002-04-02 |
ドクター・レディーズ・リサーチ・ファウンデーション |
抗潰瘍剤として新規なベンゾイミダゾール誘導体、それらの製造方法、及びそれらを含有する薬学的組成物
|
AU9067198A
(en)
|
1997-07-25 |
1999-02-16 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Proton pump inhibitor in therapeutic combination with antibacterial substances
|
US7230014B1
(en)
*
|
1997-10-14 |
2007-06-12 |
Eisai Co., Ltd. |
Pharmaceutical formulation comprising glycine as a stabilizer
|
ES2268800T3
(es)
*
|
1997-10-14 |
2007-03-16 |
Eisai Co., Ltd. |
Formulacion farmaceutica que comprende glicina como estabilizador.
|
US6861448B2
(en)
|
1998-01-14 |
2005-03-01 |
Virtual Drug Development, Inc. |
NAD synthetase inhibitors and uses thereof
|
DE69918799D1
(de)
|
1998-01-14 |
2004-08-26 |
Uab Res Foundation Birmingham |
Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
|
DE19815634A1
(de)
*
|
1998-04-07 |
1999-10-14 |
Bayer Ag |
Verfahren zur Herstellung von 3-Methoxy-1-propanol
|
AU3870599A
(en)
*
|
1998-04-30 |
1999-11-16 |
Sepracor, Inc. |
R-rabeprazole compositions and methods
|
WO1999055158A1
(en)
*
|
1998-04-30 |
1999-11-04 |
Sepracor Inc. |
S-rabeprazole compositions and methods
|
AU4387799A
(en)
*
|
1998-06-26 |
2000-01-17 |
Russinsky Limited |
Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds
|
ES2192394T3
(es)
|
1998-08-10 |
2003-10-01 |
Winston Pharmateuticals Llc |
Profarmacos de inhibidores de la bomba de protones.
|
US6093734A
(en)
*
|
1998-08-10 |
2000-07-25 |
Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin |
Prodrugs of proton pump inhibitors
|
PT1105105E
(pt)
|
1998-08-12 |
2006-07-31 |
Altana Pharma Ag |
Forma de administracao oral para piridin-2-ilmetilsulfinil-1h-benzimidazois
|
DE19843413C1
(de)
*
|
1998-08-18 |
2000-03-30 |
Byk Gulden Lomberg Chem Fab |
Neue Salzform von Pantoprazol
|
JP3926936B2
(ja)
|
1998-11-16 |
2007-06-06 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スルホキシド誘導体・アセトン錯体およびその製造法
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
US6362202B1
(en)
|
1999-03-02 |
2002-03-26 |
Sepracor Inc. |
Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
|
US6353005B1
(en)
|
1999-03-02 |
2002-03-05 |
Sepracor, Inc. |
Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
|
US6174902B1
(en)
|
1999-04-28 |
2001-01-16 |
Sepracor Inc. |
R-rabeprazole compositions and methods
|
IL146504A0
(en)
|
1999-06-07 |
2002-07-25 |
Byk Gulden Lomberg Chem Fab |
Pharmaceutical compositions containing an acid-labile active compound and processes for the preparation thereof
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
AU2001251083A1
(en)
*
|
2000-03-31 |
2001-10-15 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
|
WO2001097753A2
(en)
|
2000-06-19 |
2001-12-27 |
Eisai Co. Ltd. |
Novel methods using pyridine derivatives
|
US6544556B1
(en)
*
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
KR20030059318A
(ko)
|
2000-12-07 |
2003-07-07 |
알타나 파마 아게 |
산 불안정성 활성 성분을 포함하는 현탁액 형태의 약학 제제
|
EP1341528B1
(de)
|
2000-12-07 |
2012-01-18 |
Nycomed GmbH |
Schnell zerfallende tablette mit einem säurelabilen wirkstoff
|
CA2430816C
(en)
|
2000-12-07 |
2012-05-15 |
Altana Pharma Ag |
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
|
NL1018295C2
(nl)
*
|
2001-06-15 |
2002-12-17 |
Dsm Nv |
Werkwijze voor de bereiding van 4-chloor-pyridine-n-oxiden.
|
AU2002332178B2
(en)
|
2001-09-18 |
2005-12-08 |
Zeria Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
AU2002365936A1
(en)
*
|
2001-11-16 |
2003-09-02 |
Eisai Co. Ltd |
Compositions and methods to treat gastrointestinal disorders
|
SE0104295D0
(sv)
*
|
2001-12-18 |
2001-12-18 |
Astrazeneca Ab |
New process
|
WO2003082858A1
(en)
*
|
2002-03-26 |
2003-10-09 |
Dr. Reddy's Laboratories Limited |
Crystalline forms of rabeprazole sodium
|
AU2003241464A1
(en)
*
|
2002-05-17 |
2003-12-02 |
Eisai Co., Ltd. |
Compositions and methods using proton pump inhibitors
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
TW200410955A
(en)
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
CA2493618A1
(en)
*
|
2002-08-01 |
2004-02-12 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
AT413538B
(de)
*
|
2002-10-01 |
2006-03-15 |
Dsm Fine Chem Austria Gmbh |
Verfahren zur herstellung von substituierten pyridin-n-oxid-verbindungen
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
EP1575941B1
(de)
|
2002-12-06 |
2012-04-11 |
Nycomed GmbH |
Verfahren zur Herstellung von (S)-Pantoprazol
|
KR101062806B1
(ko)
|
2002-12-06 |
2011-09-07 |
니코메드 게엠베하 |
광학적으로 순수한 활성 화합물의 제조 방법
|
EP1575937A2
(de)
*
|
2002-12-16 |
2005-09-21 |
Ranbaxy Laboratories, Ltd. |
Rabeprazol calzium salz
|
JP2006514108A
(ja)
*
|
2002-12-19 |
2006-04-27 |
テバ ファーマシューティカル インダストリーズ リミティド |
パントプラゾールナトリウムの固体状態、それらの調製方法、及び公知のパントプラゾールナトリウム水和物の調製方法
|
EP1583507A2
(de)
*
|
2003-01-07 |
2005-10-12 |
Ranbaxy Laboratories Limited |
Magnesiumsalz eines imidazol-derivats
|
US20040180935A1
(en)
*
|
2003-02-28 |
2004-09-16 |
Dr. Reddy's Laboratories Limited Dr. Reddy's Laboratories Inc. |
Crystalline form Z of rabeprazole sodium and process for preparation thereof
|
EP1601667A2
(de)
*
|
2003-03-12 |
2005-12-07 |
Teva Pharmaceutical Industries Limited |
Kristalline und amorphe festformen von pantoprazol und vervahren zu ihrer herstellung
|
US7608625B2
(en)
*
|
2003-03-13 |
2009-10-27 |
Eisai R & D Management Co., Ltd. |
Method for treating bruxism and bruxism-related diseases
|
KR100714375B1
(ko)
|
2003-03-24 |
2007-05-02 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
술폭시드 유도체 또는 그 염의 아몰퍼스의 제조방법
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
US7524837B2
(en)
*
|
2003-05-12 |
2009-04-28 |
Janssen Pharmaceutica N.V. |
Benzotriazapinone salts and methods for using same
|
US7683177B2
(en)
*
|
2003-06-10 |
2010-03-23 |
Teva Pharmaceutical Industries Ltd |
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
|
US8802139B2
(en)
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
BRPI0412590A
(pt)
*
|
2003-07-15 |
2006-09-19 |
Allergan Inc |
processo para preparação de pró-drogas isomericamente puras de inibidores de bomba de próton
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
AU2004268383A1
(en)
*
|
2003-09-03 |
2005-03-10 |
Agi Therapeutics Limited |
Proton pump inhibitor formulations, and methods of preparing and using such formulations
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US20060241037A1
(en)
*
|
2003-10-03 |
2006-10-26 |
Allergan Inc. |
Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
WO2005077936A1
(en)
|
2004-02-11 |
2005-08-25 |
Ulkar Kimya Sanayii Ve Ticaret A.S. |
Pyridine benzimidazole sulfoxides with high purity
|
US20070161679A1
(en)
*
|
2004-02-18 |
2007-07-12 |
Allergan, Inc. |
Method and compositions for the intravenous administration of compounds related to proton pump inhibitors
|
EP1715861A2
(de)
*
|
2004-02-18 |
2006-11-02 |
Allergan, Inc. |
Prodrugs von protonenpumpinhibitoren enthaltende zusammensetzungen
|
JP2007532677A
(ja)
*
|
2004-04-16 |
2007-11-15 |
サンタラス インコーポレイティッド |
プロトンポンプ阻害剤、緩衝剤、および運動促進薬の組み合わせ
|
PT1746980E
(pt)
*
|
2004-05-07 |
2012-01-25 |
Nycomed Gmbh |
Forma de dosagem farmacêutica compreendendo granulados assim como o seu processo de fabrico
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US7557217B2
(en)
*
|
2004-06-30 |
2009-07-07 |
Eisai R&D Management Co., Ltd. |
Process for production of benzimidazole derivative salt precipitate
|
US8394409B2
(en)
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
EP1775292B1
(de)
*
|
2004-08-06 |
2012-06-27 |
Eisai R&D Management Co., Ltd. |
Salze von benzimidazolderivaten mit aminen und verfahren zu deren herstellung
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
WO2006024890A1
(en)
*
|
2004-08-30 |
2006-03-09 |
Apollo International Limited |
Improved process for rabeprazole sodium in amorphous form
|
CN100364989C
(zh)
*
|
2004-09-30 |
2008-01-30 |
江苏豪森药业股份有限公司 |
拉唑类衍生物及其盐和用途
|
US20080070942A1
(en)
*
|
2004-09-30 |
2008-03-20 |
Jiangsu Hansen Pharmaceutical Co., Ltd. |
Prazole derivatives and salts thereof and use of same
|
KR20070109985A
(ko)
|
2004-11-22 |
2007-11-15 |
아나디스 리미티드 |
생물활성 조성물
|
DE602006015287D1
(de)
|
2005-02-21 |
2010-08-19 |
Cipla Ltd |
Neues verfahren zur synthese von protonenpumpenhemmern
|
US20080071089A1
(en)
*
|
2005-03-30 |
2008-03-20 |
Lupin Limited |
Process for the Manufacture of Rabeprazole Sodium
|
US7601737B2
(en)
|
2005-07-26 |
2009-10-13 |
Nycomed Gmbh |
Isotopically substituted proton pump inhibitors
|
GB0525710D0
(en)
*
|
2005-12-17 |
2006-01-25 |
Pliva Hrvatska D O O |
An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
EP1818331A1
(de)
|
2006-02-14 |
2007-08-15 |
EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. |
Verfahren zur Herstellung von 2-[{4-(3-Methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazol wesentlich frei von Sulfonverunreinigung
|
EP2003130B1
(de)
*
|
2006-03-10 |
2011-11-16 |
aRigen Pharmaceuticals, Inc. |
Neues pyridinderivat mit wirkung gegen helicobacter pylori
|
CN101453993A
(zh)
|
2006-04-03 |
2009-06-10 |
伊萨·奥迪迪 |
含有机溶胶涂层的受控释放递送物件
|
KR100771655B1
(ko)
*
|
2006-04-24 |
2007-10-30 |
주식회사 카이로제닉스 |
라베프라졸 및 그 중간체의 제조방법
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US7786309B2
(en)
|
2006-06-09 |
2010-08-31 |
Apotex Pharmachem Inc. |
Process for the preparation of esomeprazole and salts thereof
|
US7863330B2
(en)
|
2006-06-14 |
2011-01-04 |
Rottapharm S.P.A. |
Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
|
WO2008017020A2
(en)
*
|
2006-08-03 |
2008-02-07 |
Dr. Reddy's Laboratories Limited |
Process for preparing proton pump inhibitors
|
US20100317689A1
(en)
*
|
2006-09-19 |
2010-12-16 |
Garst Michael E |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
GB2444593B
(en)
|
2006-10-05 |
2010-06-09 |
Santarus Inc |
Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
|
US20110009624A9
(en)
*
|
2006-10-13 |
2011-01-13 |
Masato Ueda |
Benzimidazole compounds having gastric acid secretion inhibitory action
|
MX2009004475A
(es)
|
2006-10-27 |
2009-08-12 |
Univ Missouri |
Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
|
KR101283682B1
(ko)
|
2006-12-18 |
2013-07-08 |
링크 제노믹스 가부시키가이샤 |
위산 분비 억제작용을 지닌 헬리코박터 피로리 제균제
|
ITMI20062449A1
(it)
|
2006-12-19 |
2008-06-20 |
Dipharma Spa |
Forma cristallina di rabeprazolo sodico
|
EP3628307A1
(de)
|
2006-12-22 |
2020-04-01 |
Ironwood Pharmaceuticals, Inc. |
Zusammensetzung mit gallensäurekomplexbildnern zur behandlung von erkrankungen der speiseröhre
|
CA2679741A1
(en)
*
|
2007-03-15 |
2008-09-18 |
Sun Pharma Advanced Research Company Ltd. |
Novel prodrugs
|
EP2162449A4
(de)
*
|
2007-05-25 |
2011-07-13 |
Hetero Drugs Ltd |
Verbessertes verfahren für amorphes rabeprazolnatrium
|
WO2008155780A2
(en)
*
|
2007-06-21 |
2008-12-24 |
Matrix Laboratories Ltd |
Improved process for the preparation of pure rabeprazole
|
EP2181106A1
(de)
*
|
2007-07-17 |
2010-05-05 |
Ranbaxy Laboratories Limited |
Verfahren zur herstellung von pantoprazol-natrium und pantoprazol-natrium-sesquihydrat
|
CN101497604B
(zh)
*
|
2008-01-30 |
2012-09-26 |
山东轩竹医药科技有限公司 |
含有被烷氧乙酰胺基氧基取代的吡啶的苯并咪唑衍生物
|
CN101497603B
(zh)
*
|
2008-01-30 |
2012-11-07 |
山东轩竹医药科技有限公司 |
含有被烷氧烷胺氧基取代的吡啶的苯并咪唑衍生物
|
SI22806A
(sl)
*
|
2008-06-23 |
2009-12-31 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Nove kristalinične oblike natrijevega rabeprazola
|
AU2010235726B2
(en)
|
2009-04-09 |
2012-01-19 |
Link Genomics, Inc. |
Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-Helicobacter pylori action
|
WO2010134099A1
(en)
|
2009-05-21 |
2010-11-25 |
Cadila Healthcare Limited |
One pot process for preparing omeprazole and related compounds
|
WO2011004281A1
(en)
|
2009-07-09 |
2011-01-13 |
Alembic Limited |
A process for the preparation of amorphous form of rabeprazole sodium
|
CN102140099A
(zh)
|
2010-02-02 |
2011-08-03 |
山东轩竹医药科技有限公司 |
新的吡啶衍生物
|
CA2795056C
(en)
*
|
2010-03-31 |
2015-03-24 |
Ranbaxy Laboratories Limited |
Salts of dexlansoprazole and their preparation
|
CN102219777B
(zh)
*
|
2010-04-19 |
2013-06-05 |
江苏豪森药业股份有限公司 |
制备雷贝拉唑钠的方法
|
CN101805327B
(zh)
*
|
2010-04-29 |
2012-11-21 |
郝志艳 |
一种雷贝拉唑钠化合物及其制法
|
WO2012027331A1
(en)
|
2010-08-27 |
2012-03-01 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
WO2013088109A1
(en)
|
2011-12-16 |
2013-06-20 |
Oxagen Limited |
Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
|
CN104203938A
(zh)
|
2012-01-21 |
2014-12-10 |
朱比兰特生命科学有限公司 |
用于制备2-吡啶基甲基亚硫酰基苯并咪唑、它们的类似物和光学活性对映体的方法
|
WO2014091450A1
(en)
|
2012-12-12 |
2014-06-19 |
Ranbaxy Laboratories Limited |
Process for the preparation of rabeprazole
|
ES2906114T3
(es)
|
2013-01-15 |
2022-04-13 |
Ironwood Pharmaceuticals Inc |
Forma de dosificación oral gastrorretentiva de liberación sostenida de un secuestrante de ácidos biliares
|
CN103073536B
(zh)
*
|
2013-01-17 |
2015-06-24 |
丽珠医药集团股份有限公司 |
一种艾普拉唑的制备方法
|
CN103709141A
(zh)
*
|
2013-10-14 |
2014-04-09 |
寿光富康制药有限公司 |
雷贝拉唑钠的晶型及无定形形式
|
CN104119315B
(zh)
*
|
2014-05-21 |
2016-03-02 |
丽珠医药集团股份有限公司 |
一种雷贝拉唑钠的制备方法
|
RU2554735C1
(ru)
*
|
2014-08-20 |
2015-06-27 |
Открытое Акционерное Общество "Татхимфармпрепараты" |
Фармацевтическая композиция, содержащая рабепразол натрия, и способ ее получения
|
US20180015118A1
(en)
|
2015-02-03 |
2018-01-18 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating upper gastrointestinal disorders in ppi refractory gerd
|
WO2016174664A1
(en)
|
2015-04-29 |
2016-11-03 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
WO2017145146A1
(en)
|
2016-02-25 |
2017-08-31 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
CN106083705A
(zh)
*
|
2016-06-14 |
2016-11-09 |
上药康丽(常州)药业有限公司 |
2‑羟甲基‑4‑(甲氧基丙氧基)‑3‑甲基吡啶盐酸盐的制备方法
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
CN106349220A
(zh)
*
|
2016-08-25 |
2017-01-25 |
岳阳正昊化学科技有限公司 |
一种右旋雷贝拉唑钠的纯化方法
|
CN110545804A
(zh)
|
2016-09-24 |
2019-12-06 |
华盛顿大学 |
Sarm1 nad酶活性抑制剂及其用途
|
US20230068960A1
(en)
|
2019-09-24 |
2023-03-02 |
Prolacta Bioscience, Inc. |
Compositions and methods for treatment of inflammatory and immune diseases
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|